Arbutin Reshapes Intestinal Microbiota to Ameliorate Lipid Metabolic Dysfunction and Inflammation.
Gut microbial dysbiosis drives obesity-related metabolic disorders. This study investigated whether arbutin, a phenolic glycoside, alleviates obesity via gut microbiota modulation. In obese mice, arbutin reduced body weight, improved glucose and lipid profiles, suppressed adipogenic and inflammatory gene expression, an...